
AUSAF
Healthcare · Drug Manufacturers - Specialty & Generic · $2,782 market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2021
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 2, 2022 | Time not confirmed | — | -0.12 | — |
| Mar 1, 2022 | After the close | — | -0.02 | — |
| Nov 22, 2021 | Time not confirmed | — | -0.01 | — |
| Sep 30, 2021 | Time not confirmed | — | -0.01 | — |
| Jun 30, 2021 | Time not confirmed | — | -0.03 | — |
| Mar 31, 2021 | Time not confirmed | — | 0.01 | — |
| Dec 31, 2020 | Time not confirmed | — | -0.09 | — |
| Jul 2, 2020 | After the close | — | -0.03 | — |
| Jun 30, 2020 | Time not confirmed | — | -0.01 | — |
| Feb 27, 2020 | After the close | — | -0.04 | — |
| Nov 27, 2019 | Before the open | — | -0.03 | — |
| Jul 31, 2019 | After the close | — | -0.03 | — |
| Jun 30, 2019 | Time not confirmed | — | -0.01 | — |
| Feb 28, 2019 |
Australis Capital Inc. operates as a cannabis company in the United States and internationally. The company was incorporated in 2018 and is based in Las Vegas, Nevada.
| After the close |
| — |
| 0.01 |
| — |
| Nov 28, 2018 | After the close | — | -0.01 | — |
| Aug 31, 2018 | After the close | 0.00 | -0.02 | — |
| Jun 30, 2018 | Time not confirmed | 0.00 | -0.05 | — |